H

Heron Therapeutics

HRTX

2.80000
USD
-0.17
(-5.72%)
Market Closed
Volume
56,116
EPS
0
Div Yield
0
P/E
-7
Market Cap
269,210,730
Related Instruments
AMGN
2.78
(0.84%)
335.22 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
I
INO
-0.670
(-6.28%)
10.000 USD
MRNA
-25.020
(-20.99%)
94.160 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SGEN
0
(0%)
0.000000 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Heron Therapeutics

Sector: Healthcare
Industry: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.